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ABSTRACT 
Two former classmates aged 58 with a history of more than 20 years of elevated liver function 
tests presented to our clinic. As they were both tested positive for antimitochondrial 
antibodies and liver biopsy showed distinctive bile duct lesions, they were given the diagnosis 
of primary biliary cirrhosis. To confirm presence of AMAs and subtype of AMAs western 
blotting was performed showing two distinct bands at 62 kD (PDH-E2) and 48 kD (2ODH-
E2) in patient 1 and only one band at 62 kD in patient 2. Searching for potential explanations 
for this unusual occurence of this rare disease in two close friends a comparison of restriction 
fragment lengths polymorphism was performed and excluded any familial relationship. 
Interestingly, histocompatibility leukocyte antigen typing revealed strong similarities as they 
both shared A2, B51, DR4, DR8 and DR53. These results may point to an unknown 
environmental factor what caused primary biliary cirrhosis in immunologically susceptible 
individuals. 
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INTRODUCTION 
 
Primary biliary cirrhosis (PBC) is a chronic 
cholestatic disease involving immune 
mediated destruction of the intrahepatic bile 
ducts. The course is slowly progressive 
leading to periportal fibrosis and ultimately 
cirrhosis requiring transplantation of the 
liver. Recently, using cryopreserved primary 
hepatocytes and transdifferentiation of stem 
cells to hepatic phenotypes future options for 
therapies of slowly progressive liver diseases 
have been demonstrated (Steinberg et al., 
1999; Hengstler et al., 2000a,b; Beerheide et 
al., 2002). The most characteristic immune 
abnormality is the presence of 
antimitochondrial antibodies (AMA; Kaplan,  
 
 
1987). Different types of mitochondrial 
autoantigens have been described, but only 
antibodies against the M2 autoantigen have 
been demonstrated to be specific for primary 
biliary cirrhosis. For the M2 autoantigen two 
subunit enzymes of a functionally related 
enzyme family have been identified, the E2 
subunit of the pyruvate dehydrogenase 
complex (PDH-E2) and the E2 component of 
the 2-oxo-acid-dehydrogenase complex 
(2ODH-E2; Gershwin and Mackay, 1991). 
The question as to what triggers the initial 
bile duct lesion in primary biliary cirrhosis, - 
genetical, environmental, or defective 
immunoregulation alone – has yet not been 
answered. 
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PATIENTS 
 
Case report 1 
Patient 1 was the 58-year-old female first 
presented in 1995 with a 26 year history of  
 
intermittent elevations of serum 
aminotranferases. As demonstrated in table 1 
serologic studies were positive for AMA and 
antinuclear autoantibodies (ANA). 
 
 
Table 1: Comparison of serology and serum chemistry of the presented patients 
 
Parameter Patient 1 Patient 2 
AMA (IFT) 1:20 1:80 
anti-PDH-E2 (ELISA, %) neg 56 
anti-2ODH-E2 (ELISA, %) 51 Neg 
ANA (IFT) 1:80 Neg 
SMA (IFT) neg Neg 
SLA (IFT) neg Neg 
LKM (IFT) neg Neg 
ALT (U/L) 42 54 
AST (U/L) 36 28 
AP (U/L) 125 282 
γ-GT (U/L) 38 48 
Total Bilirubin (µmol/L) 18.0 24.1 
IgG (g/L) 16.3 10.2 
IgM (g/L) 1.96 1.69 
Total γ-globulin (relative %) 21.6 13.9 
 
Smooth muscle antibodies (SMA), soluble 
liver antigen antibodies (SLA), and liver-
kidney-microsomal antibodies (LKM) were 
not detectable. Serology for hepatitis A, B, C, 
and D was negative. Electrophoresis showed 
moderate hypergammaglobulinemia 
primarily due to elevated immunoglobulin G 
(IgG) levels (see table 1). Laparoscopy 
showed moderate liver fibrosis and 
histological findings on liver biopsy were 
chronic hepatitis with moderate 
inflammatory activity, occasional piecemeal 
necroses, distinct portal fibrosis, and 
accompaning cholangitis. On the basis of 
these findings the patient was considered to 
suffer from PBC, better termed chronic 
nonsuppurative destructive cholangitis, with 
secondary autoimmune hepatitis (AIH). The 
patient was started on treatment with 
ursodeoxycholic acid (UDCA, 750 mg/d) and 
immunosuppression with tapering doses of 
prednisolone and azathioprine (50mg/d) as is 
our standard practice (Meyer zum 
Büschenfelde and Lohse, 1995). During 
follow-up the patient showed a good 
response with histologically less 
inflammatory activity without necroses and 
complete normalization of liver function tests 
(alanine aminotransferase (ALT) 17 U/L, 
aspartate aminotransferase (AST) 32 U/L, 
alkaline phosphatase (AP) 128, γ-glutamyl 
tranpeptidase (γ-GT) 19 U/L, and total 
bilirubin 14.2 µmol/L). 
 
Case report 2 
In 1997 a former classmate of the first patient 
came to our clinic. They shared the same 
table at primary school from 6th till 10th year 
of age and had been friends since then. 
Though they were born in a relatively small 
town, they denied any familial relationship. 
The second patient was the 58-year-old 
female with a past medical history including 
23 years of abnormal liver function tests and 
two episodes of jaundice: (i) At the age of 7 
the patient experienced an acute hepatitis 
probably explained by a hepatitis A virus 
(HAV) infection, as family members and 
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close friends were also be affected. (ii) 
During her first pregnancy at the age of 22 
she complained of recurrent colicky pain in 
the upper abdomen and developed scleral 
icterus. Cholangiography performed after this 
pregnancy was normal pointing to a 
pregnancy jaundice frequently being the first 
symptom of primary biliary cirrhosis. 
 
As demonstrated in table 1 serum chemistry 
showed moderately elevated ALT, AP, γ-GT, 
and total bilirubin and a normal AST. She 
also had a combined hyperlipoproteinemia 
with triglycerides of 3.59 mmol/L and 
cholesterol of 5.34 mmol/L under treatment 
with a HMG-CoA reductase inhibitor. 
Gamma-globulins, IgG and IgM fractions 
were within the normal range. Serologic tests 
were positive for AMA and anti-HAV IgG. 
Anti-HAV IgM and Hepatitis B, C, and D 
testing was negative. Histology showed 
primary biliary cirrhosis grade 2 with 
lymphocytic inflammatory infiltration of bile 
ducts, necrosis of bile duct epithelia, and 
focal bile duct proliferation. Therefore, the 
patient was given the diagnosis of primary 
biliary cirrhosis with combined 
hyperlipoproteinemia and received treatment 
with UDCA (750 mg/d). 
 
 
MATERIALS AND METHODS 
 
ELISA. Mitochondrial autoantibodies against 
PDH-E2 and 2ODH-E2 were diagnosed by 
inhibition enzyme-linked immunosorbent 
assay (ELISA) based on the description of 
Manns et al. (1987). This assay is based on 
the capability of a test serum to inhibit the 
binding of a labelled indicator AMA-positive 
serum to PDH-E2 or 2ODH-E2 indicating 
the presence of anti-PDH-E2 or anti-2ODH-
E2-antibodies in the test serum. Microtiter 
plates were coated with 50 µl of gamma 
globulins (20µg/ml) of an anti-PDH-E2-
positive or anti-2ODH-E2-positive serum 
and postcoated with 1% BSA in PBS. After 
washing, 50 µl (200 µg/ml) of mitoblasts 
from rat prepared as 100,000 g supernatant 
by differential centrifugation as described 
previously (Manns et al., 1987) were added. 
After washing of unbound antigen, the plates 
were incubated with 50 µl of biotinylated 
gamma globulins of the indicator serum (10 
µg/ml) in 1% BSA/PBS. Binding of the 
indicator serum was detected with 50 µl of 
avidin-peroxidase (1:1500 in 1% BSA/PBS) 
and ABTS solution (Sigma, Deisenhofen, 
Germany). Samples were measured at 
λ402nm in a Titertec Multiscan MC (Flow 
Laboratories, Meckenheim, Germany). Sera 
were considered anti-PDH-E2 or anti-2ODH-
E2 positive, if binding of the indicator serum 
was inhibited by more than 40% (i.e. above 
two standard deviations of inhibition by 
normal sera). 
 
Western Blot. SDS PAGE was performed 
with a 10% running gel and a 4.5% stacking 
gel based on the method of Laemmli (1970) 
as described previously (Herkel et al., 1997). 
A Mini Protean II Electrophoresis chamber 
(BioRad, Munich, Germany) was used and 
200 µg of rat mitoblasts (prepared as 
described above) were applied to the gel. 
Proteins were transferred to a polyvinyl-
difluoride (PVFD) membrane (Millipore, 
Eschborn, Germany). For immunoenzymatic 
detection patient sera were diluted 1:200 and 
peroxidase conjugated anti-human IgG, IgA, 
IgM, kappa, lambda (Dako, Kopenhagen, 
Denmark) were diluted 1:1000. Immunoblots 
were developed with metal-enhanced 
diaminobenzidine kit (Boehringer, 
Mannheim, Germany). The following 
immunoblots were carried out according to 
Towbin et al. (1979). Sera were diluted 
1:200. 
 
Additionally, histocompatibility leukocyte 
antigen (HLA) typing was performed and 
restriction fragment lengths polymorphism of 
both patients was analysed as previously 
described (Hohler et al., 1996; Kaluza et al., 
2001). 
 
RESULTS 
 
At the day of presentation both patients were 
tested positive for either anti-PDH-E2 or 
anti-2ODH-E2 (see table 1). During follow-
up results of ELISA in patient 1 were 
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repeatedly positive for anti-PDH-E2 and anti-
2ODH-E2, and in patient 2 anti-PDH-E2 
occasionally was not detectable. To confirm 
presence of AMAs and subtype of AMAs 
western blotting was performed showing two 
distinct bands at 62 kD (PDH-E2) and 48 kD 
(2ODH-E2) in patient 1 and only one band at 
62 kD in patient 2 (Fig. 1). 
Histocompatibility leukocyte antigen typing 
revealed strong similarities as both patients 
shared A2, B51, DR4, DR8 and DR53 
(Table 2). Genetic differences between both 
individuals could be evidenced by analysis of 
restriction fragment lengths polymorphism 
showing a wide chromosomal variability. 
 
 
Fig. 1: Western Blot showing two distinct 
bands at 62 kD (the E2 subunit of the 
pyruvate dehydrogenase complex; PDH-
E2) and 48 kD (the E2 component of the 2-
oxo-acid-dehydrogenase complex; 2ODH-
E2) in patient 1 (1) and only one band at 62 
kD in patient 2 (2) as compared to a control 
with no human serum (N) and a pooled 
serum of healthy human subjects (C). 
Table 2: Histocompatibility leukocyte antigen (HLA) typing of the presented patients 
 
HLA A B C DR DQ  
Case 1 2/3 51/50 w6 4/8 7/8 DR53 
Case 2 2/24 51/60 w3 4/8 3/4 DR53 
 
 
DISCUSSION 
 
We described the occurence of primary 
biliary cirrhosis in adulthood in two patients 
who were close friends for most of their early 
schoolyears. Four explanations for this 
observation came to mind: (i) chance 
occurence; (ii) common environmental risks; 
(iii) common genetic risks; (iv) common 
immunological susceptibility. 
 
(i) As the prevalance of primary biliary 
cirrhosis in West Germany was shown to be 
only 0.7 per 100,000 inhabitants (Triger et 
al., 1984) chances are almost zero that patient 
1 and patient 2 who visited the same class at 
primary school developed primary biliary 
cirrhosis by coincidence. 
 
(ii) In both patients intermittent elevations of 
liver enzymes were known for about 25 
years. Considering the slow and insidious 
progression typical for primary biliary 
cirrhosis, the exposure to an unknown 
causative agent could possibly have taken 
place during their visit of primary school till 
10th year of age. What particular agent could 
have been responsible for the development of 
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primary biliary cirrhosis in these patients? In 
1980 Triger et al. demonstrated for the city of 
Sheffield, that there occured an apparent 
clustering of cases in districts supplied by the 
same water reservoir, but further 
investigations failed to show any striking 
difference in this water compared to other 
reservoirs. Burroughs et al. (1992) supported 
the hypothesis of infection as a trigger for 
primary biliary cirrhosis when Escherichia 
coli was found to share epitopes with PDH-
E2 indicating that molecular mimicry may 
lead to primary biliary cirrhosis. The 
existence of a transmissible infectious agent 
was recently discussed by Delpre and Niv 
(1998) when they reported of primary biliary 
cirrhosis occuring in a married couple. 
Nevertheless, thus far, no environmental 
agent causing this chronic liver disease could 
be determined. 
 
(iii) Primary biliary cirrhosis has been 
described in certain families (Bach and 
Schaffner, 1994; Caldwell et al., 1992), and 
Myszor and James (1990) who carried out a 
comprehensive epidemiological study in 347 
patients with histologically confirmed 
primary biliary cirrhosis determined a 
familial incidence of 2.4%. Between the 
present two patients any familial relationship 
was denied and the genetic difference could 
be evidenced by analysis of restriction 
fragment lengths polymorphism showing a 
wide chromosomal variability among the two  
 
individuals. 
 
(iv) As defective immune response seemed to 
play a significant role in the pathogenesis of 
primary biliary cirrhosis, characteristics like 
HLA were investigated in affected 
individuals. Associations of primary biliary 
cirrhosis with HLA-DR2, DR3, DR4, and 
DR8 have been shown, being the closest to 
HLA-DR8 accounting for about one third of 
Caucasian patients (Mackay and Gershwin, 
1998; Neuberger and Thomson, 1999). The 
present two patients shared 5 of 11 HLA loci 
tested and were positive for HLA-DR8. 
HLA-DR4 could also be detected in both 
patients possibly contributing to the hepatitic 
picture in patient 1. This allel has recently 
been described as an important HLA type 
causing susceptibility to AIH and leading to 
overlapping features of autoimmune hepatitis 
in primary biliary cirrhosis patients (Lohse et 
al., 1999). 
 
In accordance to the findings of the present 
investigation one may presume that the two 
patients could have been exposed to an 
environmental agent in childhood what made 
them develope primary biliary cirrhosis after 
decades depending on their particular HLA 
constellation. Whether this presumed agent 
was infectious, i.e. bacterial, viral, fungal, 
etc., or an unknown substance, and as to what 
degree certain HLA types may influenced the 
progress of disease remains an enigma. 
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